UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000052899 |
|---|---|
| Receipt number | R000060356 |
| Scientific Title | Assessing Pharmacists' Understanding and Practice of Urine Drug Screening for Diabetic Neuropathy Patients treated in a pain clinic a cross sectional study in Punjab, Pak |
| Date of disclosure of the study information | 2023/11/25 |
| Last modified on | 2023/11/25 05:35:45 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Assessing Pharmacists' Understanding and Practice of Urine Drug Screening for Diabetic Neuropathy Patients treated in a pain clinic a cross sectional study in Punjab, Pak
Acronym
UDSDN
Scientific Title
Assessing Pharmacists' Understanding and Practice of Urine Drug Screening for Diabetic Neuropathy Patients treated in a pain clinic a cross sectional study in Punjab, Pak
Scientific Title:Acronym
UDSDN
Region
| Asia(except Japan) |
Condition
Condition
Diabetic neuropathy
Classification by specialty
| Endocrinology and Metabolism | Rehabilitation medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To Evaluate the Level of Knowledge: Assess the depth of understanding among pharmacists regarding urine drug screening practices for diabetic neuropathy patients undergoing treatment at pain clinic
Basic objectives2
Others
Basic objectives -Others
Determine the extent to which pharmacists apply urine drug screening protocols in their practice for diabetic neuropathy patients within the pain clinic setting and ascertain their adherence to recommended guidelines.
Trial characteristics_1
Exploratory
Trial characteristics_2
Explanatory
Developmental phase
Not applicable
Assessment
Primary outcomes
To Evaluate the Level of Knowledge: Assess the depth of understanding among pharmacists regarding urine drug screening practices for diabetic neuropathy patients undergoing treatment at pain clinics in Punjab, Pakistan.
To Assess Implementation and Compliance: Determine the extent to which pharmacists apply urine drug screening protocols in their practice for diabetic neuropathy patients within pain clinic settings in Punjab, Pakistan, and ascertain their adherence to recommended guidelines.
Key secondary outcomes
Pharmacists' Confidence Levels: Assess the confidence levels of pharmacists in interpreting and acting upon urine drug screening results for diabetic neuropathy patients in pain clinic settings.
Patient Satisfaction and Understanding: Evaluate the level of satisfaction and understanding among diabetic neuropathy patients regarding the purpose and implications of urine drug screening conducted by pharmacists within pain clinic care.
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 80 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Pharmacists working in pain clinic
Key exclusion criteria
Trainees, pharmacy students and visiting pharmacists
Target sample size
50
Research contact person
Name of lead principal investigator
| 1st name | Nadia |
| Middle name | |
| Last name | Hussain |
Organization
Al Ain University
Division name
College of Pharmacy
Zip code
64141
Address
Jimi area
TEL
971505440153
nadia.hussain@aau.ac.ae
Public contact
Name of contact person
| 1st name | Saima |
| Middle name | |
| Last name | Abbass |
Organization
Shifa Hospital
Division name
Sheikhupura
Zip code
39630
Address
Shifa Hospital, Punjab
TEL
923245065017
Homepage URL
saimaabasstahammal@gmail.com
Sponsor or person
Institute
Shifa Hospital
Institute
Department
Personal name
Funding Source
Organization
Shifa Hospital
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Shifa Hospital
Address
Sheikhupura
Tel
92 324 5065017
saimaabasstahammal@gmail.com
Secondary IDs
Secondary IDs
YES
Study ID_1
SH-34987385
Org. issuing International ID_1
Shifa Hospital
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Shifa Hospital
Other administrative information
Date of disclosure of the study information
| 2023 | Year | 11 | Month | 25 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
95
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2023 | Year | 01 | Month | 05 | Day |
Date of IRB
| 2023 | Year | 01 | Month | 25 | Day |
Anticipated trial start date
| 2023 | Year | 03 | Month | 01 | Day |
Last follow-up date
| 2023 | Year | 04 | Month | 01 | Day |
Date of closure to data entry
| 2023 | Year | 10 | Month | 31 | Day |
Date trial data considered complete
| 2023 | Year | 11 | Month | 01 | Day |
Date analysis concluded
| 2023 | Year | 11 | Month | 10 | Day |
Other
Other related information
Observational study
Management information
Registered date
| 2023 | Year | 11 | Month | 25 | Day |
Last modified on
| 2023 | Year | 11 | Month | 25 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060356
